The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Cyclooxygenase Inhibitors and the Antiplatelet Effects of Aspirin
Open accessAbstract
BACKGROUND: Patients with arthritis and vascular disease may receive both low-dose aspirin and other nonsteroidal antiinflammatory drugs. We therefore investigated potential interactions between aspirin and commonly prescribed arthritis therapies METHODS: We administered the following combinations of drugs for six days: aspirin (81 mg every morning) two hours before ibuprofen (400 mg every morning) and the same medications in the reverse order; aspirin two hours before acetaminophen (1000 mg every morning) and the same medications in the reverse order; aspirin two hours before the cyclooxygenase-2 inhibitor rofecoxib (25 mg every morning) and the same medications in the reverse order; enteric-coated aspirin two hours before ibuprofen (400 mg three times a day); and enteric-coated aspirin two hours before delayed-release diclofenac (75 mg twice daily) RESULTS: Serum thromboxane B(2) levels (an index of cyclooxygenase-1 activity in platelets) and platelet aggregation were maximally inhibited 24 hours after the administration of aspirin on day 6 in the subjects who took aspirin before a single daily dose of any other drug, as well as in those who took rofecoxib or acetaminophen before taking aspirin. In contrast, inhibition of serum thromboxane B(2) formation and platelet aggregation by aspirin was blocked when a single daily dose of ibuprofen was given before aspirin, as well as when multiple daily doses of ibuprofen were given. The concomitant administration of rofecoxib, acetaminophen, or diclofenac did not affect the pharmacodynamics of aspirin CONCLUSIONS: The concomitant administration of ibuprofen but not rofecoxib, acetaminophen, or diclofenac antagonizes the irreversible platelet inhibition induced by aspirin. Treatment with ibuprofen in patients with increased cardiovascular risk may limit the cardioprotective effects of aspirin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It can also antagonize the platelet inhibition induced by low dose aspirin and lessens its cardioprotective effect (46).”
From Paracetamol: New Vistas of an Old Drug (2006) · cites this paper as [46]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bombardier, C., Laine, L., Reicin, A. S., Shapiro, D., Burgos‐Vargas, R., Davis, B. R., Day, R. O., Ferraz, M. B., Hawkey, C. J., Hochberg, M. C., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011233432103 · Cited by 4,014
Final Report on the Aspirin Component of the Ongoing Physicians' Health Study
Steering Committee of the Physicians' Health Study Research Group (1989) · New England Journal of Medicine · doi:10.1056/nejm198907203210301 · Cited by 2,267
The Coxibs, Selective Inhibitors of Cyclooxygenase-2
FitzGerald, G. A., & Patrono, C. (2001) · New England Journal of Medicine · doi:10.1056/nejm200108093450607 · Cited by 1,572
Self-citationMcAdam, B. F., Catella-Lawson, F., Mardini, I. A., Kapoor, S. C., Lawson, J. A., & FitzGerald, G. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.1.272 · Cited by 1,304
Self-citationThe X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1
Picot, D., Loll, P. J., & Garavito, R. M. (1994) · Nature · doi:10.1038/367243a0 · Cited by 1,270
Patrono, C., Coller, B. S., Dalen, J. E., Gerald, G. A. F., Fuster, V., Gent, M., Hirsh, J., & Roth, G. J. (2001) · CHEST Journal · doi:10.1378/chest.119.1_suppl.39s · Cited by 961
Patrignani, P., Filabozzi, P., & Patrono, C. (1982) · Journal of Clinical Investigation · doi:10.1172/jci110576 · Cited by 931
Flexibility of the NSAID binding site in the structure of human cyclooxygenase-2
Luong, C., Miller, A. B., Barnett, J. W., Chow, J., Ramesha, C. S., & Browner, M. F. (1996) · Nature Structural Biology · doi:10.1038/nsb1196-927 · Cited by 620
Catella-Lawson, F., McAdam, B. F., Morrison, B. W., Kapoor, S. C., Kujubu, D. A., Antes, L. M., Lasseter, K. C., Quan, H., Gertz, B. J., & FitzGerald, G. A. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38195-9 · Cited by 596
Self-citation
Flagged first, then by citations
Research works printed but not linked: 7
- Singh G, 1999, J Rheumatol, 26, 18
- Patrignani P, 1999, J Physiol Pharmacol, 50, 661
- Pathmakanthan S, 1998, Ir Med J, 91, 58
- Patrignani P, 1994, J Pharmacol Exp Ther, 271, 1705
- Sciulli MG, Patrignani P, Seta F, et al. Effects of acetaminophen on constitutive and inducible prostanoid biosynthesis in human blood cells in vitro. In: Proceedings of the 11th International Conference on Advances in Prostaglandin and Leukotriene Research: Basic Science and New Clinical Applications, Florence, Italy, June 4–8, 2000:38. abstract.
- Reilly IAG, 1987, Blood, 69, 180, 10.1182/blood.V69.1.180.180 · DOI
- Catella-Lawson F, 1999, J Pharmacol Exp Ther, 289, 735
Cited by
Sorted by citations
Items 901–1,000 of 1,000
Nakamura, H. K., Yokoyama, H., Yaguchi, T., Suzuki, Y., Tokuoka, K., Watanabe, M., Kitagawa, Y., & Yamada, Y. (2011) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.131.445 · Cited by 5
Oates, J. A. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0333 · Cited by 5
Monitoring of Antiplatelet Therapy
Gurbel, P. A., & Tantry, U. S. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-387837-3.00030-4 · Cited by 5
Antiplatelet Agents in Secondary Stroke Prevention: Selection, Timing, and Dose
Girotra, T., Lowe, F. J., Feng, W., & Ovbiagele, B. (2018) · Current Treatment Options in Neurology · doi:10.1007/s11940-018-0514-5 · Cited by 4
Hu, X., Liu, C., Zhang, M., & Zhang, W. (2022) · Pharmacogenomics · doi:10.2217/pgs-2022-0033 · Cited by 5
Schmelzer, K. P., Liebetrau, D., Kämmerer, W., Meisinger, C., & Hyhlik-Dürr, A. (2023) · Medicina · doi:10.3390/medicina59040780 · Cited by 7
Que connaît-on de la toxicité cardiovasculaire des AINS?
Sibilia, J., Deray, G., & Montalescot, G. (2006) · La Presse Médicale · doi:10.1016/s0755-4982(06)74936-3 · Cited by 5
Clinical implications of cyclooxygenase-2 inhibitors
Kawahito, Y. (2007) · Inflammation and Regeneration · doi:10.2492/inflammregen.27.552 · Cited by 5
Antiagrégants plaquettaires et diabète
Drouet, L. O., Sollier, C. B. D., & Henry, P. (2010) · Annales de Cardiologie et d Angéiologie · doi:10.1016/s0003-3928(10)70011-1 · Cited by 5
Measurements of thromboxane production and their clinical significance in coronary heart disease
Renda, G., & Caterina, R. D. (2012) · Thrombosis and Haemostasis · doi:10.1160/th12-05-0311 · Cited by 5
COX-2 inhibition and pain management: a review summary
Kiefer, W., & Dannhardt, G. (2005) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.1.3.431 · Cited by 5
Aspirin Use in Rheumatoid Arthritis Patients with Increased Risk of Cardiovascular Disease
Cote, J. K., & Bili, A. (2013) · ISRN Rheumatology · doi:10.1155/2013/589807 · Cited by 5
Genetic Signatures in the Treatment of Stroke
Munshi, A., & Sharma, V. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666140826113502 · Cited by 5
Mosleh, W., & Farkouh, M. E. (2016) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.3271 · Cited by 5
Acquired Disorders of Platelet Function
Rao, A. K. (2007) · Elsevier eBooks · doi:10.1016/b978-012369367-9/50820-x · Cited by 5
Haines, J. M., Lee, P. M., Hegedus, R. M., Hwang, J. K., & Court, M. H. (2017) · Journal of Veterinary Pharmacology and Therapeutics · doi:10.1111/jvp.12405 · Cited by 5
Bally, M., Nadeau, L., & Brophy, J. M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0201884 · Cited by 5
Redaktsiia (2015) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro20151154170-82 · Cited by 5
Aspirin resistance: Prevalence and clinical outcome in Egypt
Salah, A., El-Desuky, M., Rizk, A., & Elhadidy, A. E. (2015) · The Egyptian Journal of Critical Care Medicine · doi:10.1016/j.ejccm.2014.12.001 · Cited by 5
Younis, M. A., Hetta, . F., Abdel-Malek, M. A. Y., Ali, H. R. H., Atia, N. N., & Tawfeek, H. M. (2020) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.101851 · Cited by 5
Awtry, E. H., & Loscalzo, J. (2007) · Elsevier eBooks · doi:10.1016/b978-012369367-9/50822-3 · Cited by 5
Direct vasoprotection by aspirin: a significant bonus to antiplatelet activity?
Kojda, G. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.07.008 · Cited by 5
Patient-Specific Antiplatelet Therapy
Conde, I. D., & Kleiman, N. S. (2004) · Journal of Thrombosis and Thrombolysis · doi:10.1023/b:thro.0000036030.74243.49 · Cited by 5
Scheiman, J. M., Cryer, B., Asaka, M., Berenbaum, F., BONNET, J., Chan, F. K. L., Krejs, G. J., Lanas, Á., Weaver, A. L., & Zerbib, F. (2005) · Alimentary Pharmacology & Therapeutics Symposium Series · doi:10.1111/j.1746-6342.2005.00018.x · Cited by 5
Özdöl, Ç., Güleç, S., Rahimov, Ü., Atmaca, Y., Turhan, S., & Erol, Ç. (2006) · Thrombosis Research · doi:10.1016/j.thromres.2006.11.003 · Cited by 5
Drugs Used in Rheumatic Disease
Padjen, I. (2018) · Technical report · doi:10.1016/b978-0-444-63887-8.00003-7 · Cited by 5
Non-steroidal anti-inflammatory drugs (NSAIDs)
(2015) · Elsevier eBooks · doi:10.1016/b978-0-444-53717-1.01165-3 · Cited by 5
Importance of surface properties of affinity resin for capturing a target protein, Cyclooxygenase-1
Mori, T., Kubo, T., Kaya, K., & Hosoya, K. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.12.066 · Cited by 5
Variable response to antiplatelet therapy: what does it mean to clinicians?
Falluji, N., & Steinhubl, S. R. (2007) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.74.1.49 · Cited by 5
Thomas, D., & Giugliano, R. P. (2008) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e31816a35a2 · Cited by 5
Ibuprofen in the Prevention and Therapy of Cancer
Harris, R. E. (2015) · doi:10.1002/9781118743614.ch13 · Cited by 5
Heath, E. I., DeWeese, T. L., Partin, A. W., Marzo, A. M. D., Groopman, J. D., Nelson, W. G., Piantadosi, S. A., Lieberman, R., & Carducci, M. A. (2002) · Clinical Prostate Cancer · doi:10.3816/cgc.2002.n.021 · Cited by 5
NSAIDs and aspirin: friends or foes?
Berenbaum, F. (2003) · Joint Bone Spine · doi:10.1016/s1297-319x(02)00023-4 · Cited by 5
Aspirin resistance: myth or reality?
Singh, S., Kothari, S. S., & Bahl, V. K. (2003) · PubMed · Cited by 5
Corazzelli, G., Rios, D. D. L., Gentile, D., Corvino, S., Ricciardi, F., Pizzuti, V., Leonetti, S., D’Elia, A., Santilli, M., Aloj, F., et al. (2025) · Neurosurgery · doi:10.1227/neu.0000000000003494 · Cited by 4
Tarabichi, S., Verhey, J. T., Brinkman, J. C., Hall, R. P., Lebens, R. S., Deckey, D. G., Spangehl, M. J., & Bingham, J. S. (2025) · The Journal of Arthroplasty · doi:10.1016/j.arth.2025.05.105 · Cited by 4
Chapter 64 Antithrombotic agents for stroke prevention
Schwartz, N. E., Diener, H., & Albers, G. W. (2008) · Handbook of clinical neurology · doi:10.1016/s0072-9752(08)94064-1 · Cited by 4
New Approaches to Stroke Prevention in Atrial Fibrillation
Testai, F. D., & Gorelick, P. B. (2010) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-010-0071-z · Cited by 4
Acetylsalicylic acid enhances purinergic receptor-mediated outward currents in rat megakaryocytes
Young, J. P., Beckerman, J., Vicini, S., & Myers, A. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00422.2009 · Cited by 4
The use of Latin squares and related block designs in implementation research
Steen, I. N., Campbell, M., Eccles, M., Grimshaw, J., Ramsay, C. R., & Russell, I. T. (2014) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2014.07.007 · Cited by 4
Anti-inflammatoires non stéroïdiens et vaisseaux
Soubrier, M., Rosenbaum, D. H., Tatar, Z., Lahaye, C., Dubost, J., & Mathieu, S. (2013) · Revue du Rhumatisme · doi:10.1016/j.rhum.2012.11.012 · Cited by 4
Pharmacokinetic considerations for antithrombotic therapies in stroke
Apostolakis, S. Z., Lip, G. Y. H., & Shantsila, E. (2013) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2013.808331 · Cited by 4
Review: studies on the cardiovascular effects of selective COX-2 inhibitors show mixed results
Belknap, S. M. (2002) · BMJ Evidence-Based Medicine · doi:10.1136/ebm.7.2.49 · Cited by 4
Laboratory signs of aspirin response in haemodialysis patients
Kılıçkesmez, K., Koçaş, C., Okcun, B., Abacı, O., Kaya, A., Özkan, A. A., Görçin, B., & Gürmen, T. (2011) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365513.2011.581388 · Cited by 4
Pharmacotherapy With Antiplatelet, Anticoagulant, and Their Reversing Agents
Nguyen, A. N. D., Dasgupta, A., & Wahed, A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803531-3.00003-3 · Cited by 4
Islam, M. A., Alam, F., Sasongko, T. H., Husin, A., Abdullah, S., Gan, S. H., & Wong, K. K. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012198 · Cited by 4
Tanaka, H., Horioka, K., Yamamoto, M., Asari, M., Okuda, K., Yamazaki, K., Shimizu, K., & Ogawa, K. (2019) · Cancer Science · doi:10.1111/cas.14130 · Cited by 4
Boussofara, A., Laroussi, L., Baccouche, H., Bennour, E., Kasbaoui, S., Triki, H., Zied, I. E. H., Kammoun, I., Halima, A. B., Addad, F., et al. (2020) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-020-02969-y · Cited by 4
Provider-directed analgesia for dental pain
Myers, A. L., & Jeske, A. H. (2023) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2023.2206118 · Cited by 5
Pharmacogenetics and Pharmacogenomics Impact on Aspirin Response
Siddiqui, M. A., Jain, C., Usmani, A., Hafeez, A., Khalid, M., & Mujahid, M. (2024) · Pharmaceutical science. · doi:10.5772/intechopen.113026 · Cited by 5
Intravenous Immunoglobulin Resistant Kawasaki Disease
Navaeifar, M. R., & Rezai, M. S. (2013) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 4
The problem of cardiac safety of nonsteroidal anti-inflammatory drugs
Shostak, N. A., Клименко, А. А., Demidova, N. A., & Александрович, К. А. (2016) · Terapevticheskii arkhiv · doi:10.17116/terarkh2016885113-117 · Cited by 4
Sedation, Analgesia, and Related Topics
Miller, A., McKee, A., & Mazer, C. D. (2007) · Elsevier eBooks · doi:10.1016/b978-075067572-7.50007-2 · Cited by 4
Aspirin and Clopidogrel Resistance in Coronary Artery Disease
Hidayati, F., Irawan, B., & Mumpuni, H. (2017) · ACI (Acta Cardiologia Indonesiana) · doi:10.22146/aci.29683 · Cited by 4
Grignani, R., & Quek, S. (2019) · Pediatric Medicine · doi:10.21037/pm.2019.03.03 · Cited by 4
Albaladejo, P., Godiér, A., Mismetti, P., Roullet, S., & Steib, A. (2019) · Le Praticien en Anesthésie Réanimation · doi:10.1016/j.pratan.2019.09.001 · Cited by 4
ACETYLSALICYLIC ACID RESISTANCE: RISK FACTORS, MECHANISMS, DIAGNOSTIC TESTS
Lukianets, K. Y., & Pchelin, I. Y. (2020) · Juvenis scientia · doi:10.32415/jscientia_2020_6_2_16-34 · Cited by 4
Aspirin in ET: will twice a day keep thrombosis away?
Braunstein, E. M., & Chaturvedi, S. (2020) · Blood · doi:10.1182/blood.2020005970 · Cited by 4
Perioperative Schmerztherapie mit Nichtopioidanalgetika
Stamer, U. M., Erlenwein, J., Freys, S. M., Stammschulte, T., Stichtenoth, D. O., & Wirz, S. (2021) · Der Anaesthesist · doi:10.1007/s00101-021-01010-w · Cited by 4
Geenen, R., & Lumley (2018) · Utrecht University Repository (Utrecht University) · doi:10.3233/978-1-61499-878-5-i
Pharmacotherapy of acute orofacial pain
Sharav, Y., & Benoliel, R. (2008) · Elsevier eBooks · doi:10.1016/b978-0-7234-3412-2.10015-x · Cited by 4
Klinische Pharmakologie der aktuellen antithrombozytären Substanzen
Trenk, D., Nührenberg, T. G., Stratz, C., Valina, C. M., & Hochholzer, W. (2014) · Herz · doi:10.1007/s00059-014-4151-9 · Cited by 4
NSAIDs and Peptic Ulcer Disease
Ferraz‐Amaro, I., & Díaz‐González, F. (2011) · InTech eBooks · doi:10.5772/18607 · Cited by 4
In vivo administration of ritonavir worsens intestinal damage caused by cyclooxygease inhibitors
Renga, B., Mencarelli, A., Cipriani, S., D’Amore, C., Francisci, D., Santucci, L., Baldelli, F., Distrutti, E., & Fiorucci, S. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.11.035 · Cited by 4
Biller, J. (2008) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2008.04.023 · Cited by 4
Pallasch, T. J., Falace, D. A., Taubert, K. A., Baltimore, R. S., Wilson, W. R., Baddour, L. M., Levison, M. E., Tani, L. Y., Burns, J. C., Shulman, S. T., et al. (2004) · Cited by 4
Kirshner, H. S. (2010) · Journal of Neurology · doi:10.1007/s00415-010-5667-4 · Cited by 4
Platelet Aggregation Tests Are Affected in Pseudothrombocytopenia: Table 1
Yavaşoğlu, İ., Acar, B., Kadıköylü, G., & Bolaman, Z. (2010) · Laboratory Medicine · doi:10.1309/lm9uxaortfonz6u5 · Cited by 4
Antiplatelet Agents and Arterial Thrombosis
Billett, H. H. (2006) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2005.09.002 · Cited by 4
Tschopp, M., & Reinhart, W. H. (2008) · PubMed · Cited by 4
ANTIPLATELET DRUGS IN CARDIOVASCULAR DISEASES
Weston, C. F. M., & Rao, U. (2003) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2003.tb10638.x · Cited by 4
Özkan, H. (2018) · Turkish Journal of Thoracic and Cardiovascular Surgery · doi:10.5606/tgkdc.dergisi.2018.15489 · Cited by 4
Choosing of therapy for a patient with dorsalgia
Kamchatnov, P. R., Абусуевна, А. Б., Khanmurzaeva, S. B., & Ханмурзаева, Н. Б. (2020) · Terapevticheskii arkhiv · doi:10.26442/00403660.2020.09.000836 · Cited by 4
Antiplatelet Therapy for Secondary Prevention of Stroke
Weksler, B. B. (2004) · Elsevier eBooks · doi:10.1016/b0-44-306600-0/50065-1 · Cited by 4
Ibuprofen and cardiovascular safety: where do we stand?
Purcell, H. (2007) · PubMed · Cited by 4
Der Fokus liegt auf der individuellen Risikobewertung
Bolten, W. W., Gross, M. M., Brabant, T., Weck, V., & Labenz, J. (2013) · MMW - Fortschritte der Medizin · doi:10.1007/s15006-013-0177-9 · Cited by 4
Cost-effectiveness of different postoperative analgesic treatments
Engoren, M. (2003) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.4.9.1507 · Cited by 4
COX-2: where are we in 2003?--distinction from NSAIDs becoming blurred.
Day, R. O. (2003) · Arthritis Research · doi:10.1186/ar747 · Cited by 4
Pablos, J. L. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10505 · Cited by 4
Sotos, J. G. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.11.1374-a · Cited by 4
Current Status of NonsteroidalAnti-Inflammatory Drugsin Physiatry
Kaplan, R. J. (2005) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/01.phm.0000184155.77034.20 · Cited by 4
Kumbhani, D. J., Gibson, C. M., Kinlay, S., Peterson, E. D., Pollak, A. W., Tamis‐Holland, J. E., & Verheugt, F. W. A. (2026) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2026.05.037 · Cited by 5
Evaluation of the Role of Antiplatelet Medications in Cardiovascular Disease
Althobaiti, A. S., Alammari, A. W. A., Alalawi, A. A. A., Alhawiti, N. O. S., Al-Balawi, A. Y., Asseri, M. A. A., Saed, A. S. A., Saud, M. M., & Shaman, S. A. S. (2021) · Pharmacophore · doi:10.51847/ujvnwtzfsz · Cited by 3
Drug interactions in neurosurgical patients
Baranich, A. I., Анатольевич, С. А., Савин, И. А., & Кудрина, В. Г. (2023) · Burdenko s Journal of Neurosurgery · doi:10.17116/neiro202387061100 · Cited by 3
Influence of Ibuprofen on glycerophospholipids and sphingolipids in context of Alzheimer´s Disease
Radermacher, J., Erhardt, V. K. J., Walzer, O., Haas, E. C., Kuppler, K. N., Zügner, J. S. R., Lauer, A. A., Hartmann, T., Grimm, H. S., & Grimm, M. O. W. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.117969 · Cited by 3
Pan, W., Guan, L., & Zhang, H. (2025) · Interactive Journal of Medical Research · doi:10.2196/75363 · Cited by 3
Horváth, V. J., Tabák, Á. G., Szabó, G., Putz, Z., Koós, C. G., & Lakatos, P. L. (2015) · Orvosi Hetilap · doi:10.1556/oh.2015.30120 · Cited by 3
Pharmakotherapie des Schmerzes bei älteren Patienten mit Nichtopioiden
Burkhardt, H., & Wehling, M. (2015) · Der Schmerz · doi:10.1007/s00482-015-0032-2 · Cited by 3
Laboratory Monitoring of Antiplatelet Therapy
Gremmel, T., Bhatt, D. L., & Michelson, A. D. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813456-6.00036-9 · Cited by 5
Monitoring Commercial Ibuprofen Potency Changes Over 1 Year When Stored in a Household Setting
Archibald, T., & Brown, S. D. (2019) · Journal of Pharmacy Technology · doi:10.1177/8755122519877808 · Cited by 3
Geisler, T., & Wieland, T. (2020) · Der Kardiologe · doi:10.1007/s12181-019-00363-2 · Cited by 3
Goswami, S., Ghosh, D., Nandi, G., Mukherjee, S., & Sarkar, B. (2022) · Springer eBooks · doi:10.1007/978-981-16-4752-9_15 · Cited by 3
Patrono, C. (2017) · Springer eBooks · doi:10.1007/978-3-319-47462-5_83 · Cited by 3
Utility of constraints reflecting system stability on analyses for biological models
Kariya, Y., Honma, M., Tokuda, K., Konagaya, A., & Suzuki, H. (2022) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1010441 · Cited by 4
Elias, K. G., & Hilal, Y. (2022) · Baghdad Science Journal · doi:10.21123/bsj.2022.6860 · Cited by 3
Sone, A., Aki, K., Yasui, T., & Hosoi, E. (2023) · The Journal of Medical Investigation · doi:10.2152/jmi.70.94 · Cited by 3
Criscuolo, E., Sciscio, M. L. D., Cristofaro, A. D., Nicoara, C., Maccarrone, M., & Fezza, F. (2023) · Pharmaceuticals · doi:10.3390/ph16121678 · Cited by 3
Bolten, W. W. (2010) · Orthopedic Research and Reviews · doi:10.2147/orr.s7324 · Cited by 3
NO donor hybrid compounds as multifunctional therapeutic agents
Fang, L., & Lehmann, J. (2008) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.18.10.1111 · Cited by 3
Kang, M., & An, S. A. (2010) · Toxicology and Environmental Health Sciences · doi:10.1007/bf03217495 · Cited by 3
Metadata
- Authors
- Catella-Lawson, F., Reilly, M. P., Kapoor, S. C., Cucchiara, A. J., DeMarco, S., Tournier, B., Vyas, S. N., & FitzGerald, G. A.
- Affiliations
- University of Pennsylvania (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2001-12-20
- Volume
- 345
- Issue
- 25
- Pages
- 1809-1817
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2011327495
- Cited by
- 1,394
- References
- 44
- Citations by year
- 2026: 19 · 2025: 15 · 2024: 18 · 2023: 18 · 2022: 33 · 2021: 43 · 2020: 33 · 2019: 40 · 2018: 40 · 2017: 46 · 2016: 41 · 2015: 56 · 2014: 46 · 2013: 69 · 2012: 79
- FWCI
- 50.64
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (HL 5400, HL62250, P01HL062250)
- National Center for Research Resources (M01-RR-00040, M01RR000040)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Antiplatelet Therapy and Cardiovascular Diseases
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
- Keywords
- aspirin, ibuprofen, cyclooxygenase inhibitors, rofecoxib, diclofenac, paracetamol, drug interactions, platelet aggregation, thromboxane B2, antiplatelet activity, nonsteroidal anti-inflammatory drugs, arthritis treatment, cardiovascular risk, cardioprotection
- MeSH terms
- Acetaminophen, Adult, Anti-Inflammatory Agents, Non-Steroidal, Aspirin, Diclofenac, Drug Interactions, Drug Therapy, Combination, Humans, Ibuprofen, Isoenzymes, Lactones, Membrane Proteins, Middle Aged, Platelet Aggregation, Platelet Aggregation Inhibitors, Prostaglandin-Endoperoxide Synthases, Sulfones, Thromboxane B2, Dinoprostone, Cyclooxygenase Inhibitors, Cross-Over Studies, Analgesics, Non-Narcotic, Cyclooxygenase 1, Cyclooxygenase 2, Cyclooxygenase 2 Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
